UCB and ChemBridge in drug discovery research collaboration
Belgian company UCB and US-based ChemBridge Corporation have entered into a major collaboration in discovery chemistry.
Belgian company UCB and US-based ChemBridge Corporation have entered into a major collaboration in discovery chemistry.
UCB's drug discovery efforts based on multiple research-intensive discovery chemistry projects are to be advanced by UCB-funded ChemBridge scientists. Further details and financial terms were not disclosed.
'UCB will provide validated drug targets, and using the resource of ChemBridge's expertise in the field of discovery chemistry will speed up UCB's discovery efforts in neurological diseases,' said Edmond Differding, vice president global chemistry, UCB. 'This will rapidly advance our lead generation process in line with our patent protection strategy.'